| Stage | HAE | % of rev | SYK | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $339M | 100.00% | $6.5B | 100.00% | SYK ×19.21 |
| Gross profit | $203M | 59.76% | $4.2B | 65.15% | SYK +5.4pp |
| Operating income | $57M | 16.93% | $1.0B | 15.86% | HAE +1.1pp |
| Pre-tax income | $48M | 14.02% | $997M | 15.29% | SYK +1.3pp |
| Net income | $33M | 9.73% | $753M | 11.55% | SYK +1.8pp |
| Stage | HAE | SYK | Gap · A − B |
|---|---|---|---|
| Revenue | $339M100.00% | $6.5B100.00% | SYK ×19.21 |
| Gross profit | 59.76%$203M | 65.15%$4.2B | SYK +5.4pp |
| Operating income | 16.93%$57M | 15.86%$1.0B | HAE +1.1pp |
| Pre-tax income | 14.02%$48M | 15.29%$997M | SYK +1.3pp |
| Net income |
| 9.73%$33M |
| 11.55%$753M |
| SYK +1.8pp |
No shared counterparties.